Register entry

Sentynl Therapeutics, Inc.

Data as of · How to read this entry

Registered sites
0
Active NDC listings
4
Live patents
3
Exclusivities
2
Countries
0
Catalogue

Drug listings by form and route

4

4 active NDC listings: 4 human prescription drug. By marketing category: NDA 4.

Dosage formNDCs
capsule2
injection, powder, lyophilized, for solution2
RouteNDCs
oral2
intravenous1
subcutaneous1
Labeller name on the listingNDCs
sentynl therapeutics, inc.4
Exclusivity

Patents and exclusivities

3
PatentProductCoversExpiry
7504095NULIBRYfosdenopterin hydrobromideproductApr 2029
7838531ZOKINVYlonafarnibuseJul 2029
ProductExclusivityUntil
NULIBRYFOSDENOPTERIN HYDROBROMIDEODE-342 Orphan drugFeb 2028
ZOKINVYLONAFARNIBODE-324 Orphan drugNov 2027
Catalogue

Marketed products

4
BrandGeneric nameForm / routeNDC
Nulibryfosdenopterin hydrobromideinjection, powder, lyophilized, for solution, intravenous42358-295NDA
Zokinvylonafarnibcapsule, oral42358-450NDA
Zokinvylonafarnibcapsule, oral42358-475NDA
Zycubocopper histidinateinjection, powder, lyophilized, for solution, subcutaneous42358-329NDA
Compare

Other companies listing lonafarnib

Enquiry

Common questions

Is Sentynl Therapeutics, Inc. FDA approved?
Sentynl Therapeutics, Inc. holds no registered establishment of its own; 4 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
What drugs does Sentynl Therapeutics, Inc. make?
4 products are listed under Sentynl Therapeutics, Inc. in the openFDA NDC Directory, most often as capsule; injection, powder, lyophilized, for solution. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.